KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) Cost of Revenue (2016 - 2025)

Stereotaxis (STXS) has disclosed Cost of Revenue for 16 consecutive years, with $3.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue fell 34.0% to $3.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $14.2 million, a 7.79% increase, with the full-year FY2024 number at $12.4 million, up 3.87% from a year prior.
  • Cost of Revenue was $3.4 million for Q3 2025 at Stereotaxis, down from $4.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $5.1 million in Q3 2024 to a low of $1.5 million in Q2 2022.
  • A 5-year average of $3.2 million and a median of $3.1 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: surged 180.65% in 2021, then plummeted 51.33% in 2022.
  • Stereotaxis' Cost of Revenue stood at $3.0 million in 2021, then fell by 1.77% to $3.0 million in 2022, then plummeted by 38.94% to $1.8 million in 2023, then soared by 73.62% to $3.2 million in 2024, then increased by 6.05% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Cost of Revenue are $3.4 million (Q3 2025), $4.2 million (Q2 2025), and $3.4 million (Q1 2025).